Golimumab in the treatment of psoriatic arthritis: efficacy and safety
Tumor necrosis factor-α (TNF-α) holds a central position in the pathogenesis of autoimmune inflammatory diseases of the locomotor apparatus. A separate class of drugs, namely, TNF-α inhibitors, that are effective against multicomponent diseases, such as psoriatic arthritis (PsA), is now available to...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2015-09-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/639 |